Literature DB >> 18796380

An autopsy case of acute pulmonary toxicity related to irinotecan.

Ana Ruiz-Casado, Victor Castellano, Fernando Moreno.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18796380     DOI: 10.1007/s12094-008-0258-3

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


× No keyword cloud information.
  7 in total

1.  Irinotecan-induced interstitial pneumonia.

Authors:  O Michielin; E Udry; D Périard; O Matzinger; J A Lobrinus; R Stupp
Journal:  Lancet Oncol       Date:  2004-05       Impact factor: 41.316

Review 2.  Pulmonary drug toxicity: radiologic and pathologic manifestations.

Authors:  S E Rossi; J J Erasmus; H P McAdams; T A Sporn; P C Goodman
Journal:  Radiographics       Date:  2000 Sep-Oct       Impact factor: 5.333

Review 3.  Pulmonary toxicity from novel antineoplastic agents.

Authors:  I Dimopoulou; A Bamias; P Lyberopoulos; M A Dimopoulos
Journal:  Ann Oncol       Date:  2005-11-16       Impact factor: 32.976

4.  Irinotecan-associated pulmonary toxicity.

Authors:  Y Madarnas; P Webster; A M Shorter; G A Bjarnason
Journal:  Anticancer Drugs       Date:  2000-10       Impact factor: 2.248

5.  CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer.

Authors:  N Masuda; M Fukuoka; Y Kusunoki; K Matsui; N Takifuji; S Kudoh; S Negoro; M Nishioka; K Nakagawa; M Takada
Journal:  J Clin Oncol       Date:  1992-08       Impact factor: 44.544

6.  A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer.

Authors:  M Fukuoka; H Niitani; A Suzuki; M Motomiya; K Hasegawa; Y Nishiwaki; T Kuriyama; Y Ariyoshi; S Negoro; N Masuda
Journal:  J Clin Oncol       Date:  1992-01       Impact factor: 44.544

7.  Autopsy-proven causes of death in lungs of patients immunocompromised by secondary interstitial pneumonia.

Authors:  Alberto Antonio Terrabuio Junior; Edwin Roger Parra; Cecília Farhat; Vera Luiza Capelozzi
Journal:  Clinics (Sao Paulo)       Date:  2007-02       Impact factor: 2.365

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.